Interferon Alfa in Treating Children With HIV-Related Cancer
Completed · Phase 2
Conditions studied: Leukemia, Lymphoma, Unspecified Childhood Solid Tumor, Protocol Specific
In brief
RATIONALE: Interferon alfa may interfere with the growth of cancer cells. PURPOSE: Phase II trial to study the effectiveness of interferon alfa in treating children with an HIV-related cancer including leukemia, non-Hodgkin's lymphoma, CNS lymphoma, or other solid tumors.
Key facts
- Study ID
- NCT00002621
- Run by
- Children's Oncology Group
- People needed
- 8
- Starts
- 1994-12-01
- Expected to finish
- 2005-09-01
- Last updated by the study team
- 2014-07-24
Who can join
Age: any, up to 21. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Via Christi Regional Medical Center — Wichita, Kansas, United States
- MBCCOP - LSU Health Sciences Center — New Orleans, Louisiana, United States
- Tomorrows Children's Institute — Hackensack, New Jersey, United States
- Mission Saint Joseph's Health System — Asheville, North Carolina, United States
- Medical City Dallas Hospital — Dallas, Texas, United States
- San Antonio Military Pediatric Cancer and Blood Disorders Center — Lackland Air Force Base, Texas, United States
- University of Texas Health Science Center at San Antonio — San Antonio, Texas, United States
- McGill University Health Center - Montreal Children's Hospital — Montreal, Quebec, Canada
- University of Puerto Rico School of Medicine Medical Sciences Campus — San Juan, Puerto Rico
- Clinique de Pediatrie — Geneva, Switzerland
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.